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Assessment of DNA double-strand breaks 
induced by intravascular iodinated contrast 
media  following in vitro irradiation and in vivo, 
during paediatric cardiac  catheterization 
 
Richard Goulda, Sonyia L. McFaddena, Simon Hornb, Kevin M. Priseb, 
Philip Doylec  and  Ciara M. Hughesa* 
 
 
Paediatric cardiac  catheterizations may  result  in the  administration of substantial amounts of iodinated contrast 
media  and  ionizing  radiation. The aim  of this  work  was  to  investigate the  effect  of iodinated contrast media  in 
combination with  in vitro and  in vivo X-ray radiation on  lymphocyte DNA. Six concentrations of iodine  (15, 17.5, 
30, 35, 45, and 52.5 mg of iodine  per mL blood)  represented volumes of iodinated contrast media  used  in the clinical 
setting. Blood obtained from healthy volunteers was mixed with iodinated contrast media  and  exposed to radiation 
doses commonly used  in paediatric cardiac  catheterizations (0 mGy, 70 mGy, 140  mGy, 250  mGy and  450  mGy). 
Control  samples contained no iodine. For in vivo experimentation, pre and  post  blood samples were collected from 
children undergoing cardiac  catheterization, receiving iodine  concentrations of up to 51 mg of iodine  per mL blood 
and  radiation doses of up  to  400  mGy. Fluorescence microscopy was  performed to  assess  γH2AX-foci induction, 
which corresponded to the  number of DNA double-strand breaks. The presence of iodine  in vitro resulted in signi- 
ﬁcant  increases of DNA double-strand breaks beyond that induced by radiation for ≥17.5 mg/mL  iodine  to blood. 
The in vivo effects  of contrast media  on children undergoing cardiac  catheterization resulted in a 19% increase in 
DNA double-strand breaks in children receiving an  average concentration of 19 mg/mL  iodine  to  blood. A larger 
investigation is required to provide further information of the potential beneﬁt of lowering the amount of iodinated 
contrast media  received during X-ray radiation investigations. Copyright © 2015 John  Wiley & Sons, Ltd. 
 
Keywords:   contrast   media;   ionizing   radiation;   DNA  breaks;   double-stranded;  DNA  damage;   paediatrics;   cardiac 
catheterization 
 
1.    INTRODUCTION 
 
The average annual per-capita effective radiation dose from medi- 
cine worldwide (approximately 0.6 mSv of the total 3.0 mSv received 
from all sources) has doubled in the past 10–15 years (1). In their life- 
time, members  of the UK population  receive an average  effective 
dose of 200 mSv resulting in a fatal cancer risk of 1% (2). Children 
are of particular concern because  they are estimated to be 2-3 (3), 
and potentially up to 8-10 (4) times more radiosensitive compared 
to  adults.  The  frequency   of  paediatric  cardiac  catheterizations 
(PCC) has increased rapidly in recent years (5) resulting in substantial 
radiation exposures (6,7), which can be greater than those received 
from computed tomography (CT) (8). Although more epidemiologi- 
cal evidence is still required, 50 mGy of ionizing radiation is thought 
to triple the  risk of leukemia in children (9). Ionizing  radiation  is 
known to cause DNA lesions, of which double-strand breaks (DSBs) 
are of greatest  concern  because  of their contribution  to genetic 
instability and association with the potential development of carci- 
nogenesis (10). Radiation induced DNA DSBs develop following dis- 
ruption  of the  DNA  phosphate backbone  either  by direct  DNA 
radical production  or by radicals formed  through  water radiolysis 
(11).  The  most  widely  used  and  most  sensitive  biomarker  for 
detecting DNA DSBs as a result of low dose ionizing radiation expo- 
sure   is   the   phosphorylated   histone    variant   γH2AX   (12,13). 
Immunoﬂuorescence microscopy enables the identiﬁcation of 
γH2AX-foci, which represent  a 1:1 relationship with the number  of 
DNA DSBs (14). 
Examinations involving the  use  of iodinated  contrast  media 
(ICM)  have  increased  rapidly  in  recent  decades.  It has  been 
estimated that approximately  eight million litres of ICM are ad- 
ministered  worldwide  each  year (15). Administration  of ICM is 
commonly   used   to  visualize  cardiovascular  anatomy   during 
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procedures  such   as   CT   and   cardiac   catheterizations.    The 
presence  of ICM in the  blood  is essential  because  it enables 
the differentiation  of cardiovascular structures  and surrounding 
soft tissue on radiological images. Manufacturers of ICM provide 
recommended safe  dose  levels for administration  to  patients 
(16,17) however  during  complex cardiac catheterizations these 
levels  can  be  exceeded.  The potential  detrimental   effects  of 
ICM are well established. These include allergic reactions, hyper- 
thyroidism and contrast-induced nephropathy (18–20). However 
the inﬂuence of ICM upon DNA damage  requires further assess- 
ment  because  of the  uncertainty  of evidence  in the  literature. 
Two studies  investigating  contrast  enhanced CT have  found  a 
signiﬁcant  increase  in the  amount  of in vivo DNA damage  in 
patients   who  received  ICM compared   to  those  who  did  not 
(21,22). Similar ﬁndings have been found in vitro (23) whilst other 
authors  have  not  observed  clinically relevant  changes  (24,25). 
The purpose  of this study  was to examine  differences  in DNA 
DSBs between several  concentrations of iodine  and  radiation 
doses similar to those that may occur in PCC. 
 
 
2.    MATERIALS AND METHODS 
 
2.1.    In vitro irradiation 
 
Ethical approval was obtained  from the Ulster University, 
Jordanstown. Informed written consent was obtained  from three 
healthy  volunteers.  Each volunteer  provided  35 mLs of blood, 
drawn   up   from  the   antecubital   vein  into   vials  containing 
di-potassium ethylene diamine tetra-acetic acid to prevent 
coagulation.  The 35 mL blood sample from each volunteer  was 
divided  into 35 individual 1 mL samples  and  groups  of seven 
samples were assigned  to ﬁve radiation dose groups  of 0 mGy, 
70 mGy, 140 mGy, 250 mGy and  450 mGy. For each  radiation 
dose  the  7  x 1  mL  samples  were  assigned  to  seven  iodine 
concentrations of 0, 15, 17.5, 30, 35, 45 and  52.5 mg  iodine 
per  mL blood  (Table 1). This was  achieved  by  pipetting  the 
relevant blood volumes into eppendorf tubes containing a 
predetermined volume of ICM (Omnipaque 300, GE healthcare). 
A non-ionic ICM was chosen  for this investigation  because  it is 
standard   practice  in cardiovascular  imaging  (26). The in vitro 
iodine concentrations investigated  represented a range of 
concentrations investigated  in previous studies (21–25) and also 
corresponded to the clinical in vivo concentrations observed  in 
this  study.  A   Carestream   DRX-Evolution digital  radiography 
system was used to irradiate the blood samples. Irradiated 
eppendorf tubes  were  placed  in the  centre  of a 3.5 x 3.5 cm 
X-ray ﬁeld and  irradiated  individually using a tube  potential  of 
120 kVp and  tube  currents  of 160, 320, 560 and  1000 mA to 
achieve the desired radiation dose. 
 
 
2.2.    In vivo irradiation 
 
The in vivo irradiations were performed  as part of our ongoing 
clinical work, which aims to potentially lower radiation  dose  in 
paediatric  cardiac catheterization.  Approval for this part  of the 
study  was obtained  from the  Ofﬁce for Research Committees 
Northern Ireland and the Belfast Health and Social Care Trust. A 
total of 69 consecutive  participants  (36 males, 33 females: mean 
age 5.8 years ± 4.3: age range 0–16 years) who were scheduled 
to  undergo   paediatric  cardiac  catheterization   between  April 
2014  and  April 2015  provided  informed  written  consent   to 
participate.  The exclusion criteria was  as follows: unwilling to 
provide consent, known cancer, history of radiotherapy  or 
chemotherapy,  viral infections,  blood  disorders,  exposure   to 
toxins, history of antioxidant  supplementation, physical exercise 
two hours prior to participation. Imaging was performed  using a 
Philips Allura Xper FD10/10 bi-plane  cardiovascular  system 
(Philips Healthcare,  Amsterdam,  Netherlands).  A  1  mL blood 
sample pre and post cardiac catheterization  was obtained  from 
each  participant.  57 patients  (33 males, 24 females: mean  age 
5.4 ± 4.2) received  an average  of 19 mg iodine per mL blood 
(Iomeron  350,  Bracco  Imaging,  Milan, Italy) and  an  average 
radiation dose of 116 mGy. 12 patients  underwent unenhanced 
imaging  (four males, eight  females: mean  age  7.8 ± 4.17) and 
received  an average  radiation  dose  of 16.6 mGy. The radiation 
dose  in the  form  of air kerma  was  recorded  from  the  X-ray 
systems display panel. Each individual’s weight and sex was used 
in  combination   with  the   amount   of  ICM administered to 
determine the in vivo concentrations of iodine. 
 
 
2.3.    Lymphocyte separation 
 
All in vitro blood samples were incubated at 37 °C for 30 minutes 
in order to capture optimal DNA damage  repair by allowing time 
for DNA damage  signaling (27). The in vivo blood samples were 
stored in a blood transport cooler at 4 °C and transported 
immediately to our laboratory for immediate  analysis. All blood 
samples  were  added   to  1  mL  phosphate  buffered   solution 
(PBS) and  carefully layered  using  a  pipette   onto  lymphocyte 
separation   medium   Histopaque   1077  (Sigma-Aldrich, Dorset, 
UK). Centrifugation  was performed  at 2000 rpm for 30 minutes 
at 21 °C and  stopped without  the  use of a brake  mechanism. 
The lymphocyte  layer was aspirated  with a pipette,  placed  in 
5 mLs of PBS and centrifuged  at 1070 rpm for ﬁve minutes. The 
resulting  lymphocyte   cell  pellet  was  washed   with  PBS and 
spotted onto superfrost plus slides (Menzel-Glaser, Thermo Fisher 
Inc., Braunschweig, Germany) and left to dry for 30 minutes. Cells 
were then ﬁxed with 2% formaldehyde  for 10 minutes. 
 
 
2.4.    Immunoﬂuorescence and  microscopy 
 
Fixed cells were permeabilized using 0.5% Triton-X100 PBS for 10 
minutes  and  then  washed  with PBS. Cells were blocked  in 5% 
horse serum and 0.1% Triton-X100  PBS for 30 minutes, washed 
with PBS and incubated with 1:1000 mouse anti-H2AX phosphor- 
ylated  monoclonal  antiphospho histone  H2AX  (ser 139) clone 
(Millipore, Herfortshire, UK) in the dark for one hour at room tem- 
perature.  After washing  slides with 0.1% Triton-X100 PBS cells
 
Table  1.  Summary of the  volumes of Omnipaque  300 and  blood  mixed to achieve  the  seven  iodine concentrations prior to 
irradiation 
 
mg iodine  per  mL blood 
 
0 
 
15 
 
17.5 
 
30 
 
35 
 
45 
 
52.5 
Omnipaque 300 (μl) 0 50 58 83 116 149 175 
Blood (μl) 1000 950 942 917 884 851 825 
    
 
mg iodine 
per mL blood 
 
Mean foci and 
Standard  error 
 
Dunnet’s t-test 
(p-value) 
0 0.02 ±0.0011 (Control group) 
15 0.03 ±0.0011 0.831 
17.5 0.01 ±0.0017 0.969 
30 0.02 ±0.0005 0.600 
35 0.00 ±0.0015 0.831 
45 0.00 ±0.0001 0.372 
52.5 0.00 ±0.0003 0.203 
 
 
 
 
were incubated with Alexa Fluor 488 goat  anti-mouse  IgG, IgA, 
IgM (H&L) (Life technologies, Paisley, UK) in the dark for one hour 
at  room  temperature. As a secondary  assay, the  p53  binding 
protein  (53BP1), which accumulates  at γH2AX was also stained 
by  adding   pAb  anti-53BP1  antibody   (Novus  Biological Ltd, 
Cambridge, UK) and Alexa Fluor 568 goat  anti-rabbit  IgG (H&L) 
(Life Technologies, Paisley, UK). Slides were ﬁnally washed  with 
PBS, mounted with vectashield  hardset  DAPI (Vector Laborato- 
ries,  Peterborough,  UK)  and  protected  with  cover  slips. The 
numbers  of γH2AX-foci  were  counted  using  an  Olympus BX3 
epiﬂurescence  microscope  with  x63 objective.  100lymphocyte 
cells were scored  for each  of the  35 in vitro samples, and  due 
to dispersal  of irradiated  lymphocytes  in the  circulating blood 
300 cells were scored for in vivo samples. 
 
 
2.5.    Statistical analysis 
 
Data  is  presented  as  the   mean   and  standard   error  of  the 
allocated  in vitro radiation  and  concentration of iodine  for all 
cells counted  from the three volunteers. Dunnet’s t-test was used 
3.1.2.   Non-irradiated samples 
 
For the  non-irradiated  samples  mean  γH2AX-foci  were  ≤ 0.03 
(Table 2). Compared  to the  control  sample  without  iodine, no 
signiﬁcant difference in mean  γH2AX-foci was observed  for any 
of the concentrations of iodine (p > 0.05). 
 
 
3.1.3.   Irradiated samples 
 
An increase in the mean number of γH2AX-foci in irradiated cells 
was readily observed compared  to non-irradiated  cells (Fig. 2). In 
those  samples  without  iodine a considerable  increase  in mean 
γH2AX-foci  was observed  as radiation  dose  increased  (Fig. 3). 
The mean  γH2AX-foci clearly increased  as iodine concentration 
increased for all irradiated samples (Fig. 4). Compared to 0 mg io- 
dine  per  mL blood,  the  increase  in mean  γH2AX-foci  was not 
signiﬁcant for 15 mg iodine per mL blood, (p > 0.05). However 
the increase in mean  γH2AX-foci was signiﬁcant for iodine con- 
centrations  ≥17.5 mg iodine per mL blood (p < 0.05). The effects 
of increasing radiation dose and concentration of iodine demon- 
2
to  compare  non-irradiated   samples  with  and  without  iodine. strated  a linear increase  in mean  γH2AX-foci   (R 0.96). Iodine
One-way ANOVA was used to compare differences in γH2AX-foci 
for  baseline  samples,  radiation  doses  and  concentrations  of 
iodine.  Statistical  Package  for  Social  Science  21  (SPSS Inc., 
Chicago, IL, USA)  was used for the data analysis. After Bonferroni 
correction  for inequalities, differences  were considered  statisti- 
cally signiﬁcant  when  p  was  < 0.05. An ANCOVA  test  was 
performed for γH2AX-foci numbers for in vivo contrast enhanced 
and unenhanced examinations. The radiation dose was used as 
the covariant affecting γH2AX-foci induction. 
 
 
3.    RESULTS 
 
3.1.    Lymphocytes irradiated in vitro 
 
3.1.1.   Baseline comparison 
 
The baseline  γH2AX-foci observed  in the  three  healthy  partici- 
pants   in  non-irradiated   samples  without  iodine  are  demon- 
strated  in Fig. 1. Individual mean  baseline  levels ranged  from 
0.01-0.03 γH2AX-foci per cell and were not statistically signiﬁcant 
from each other (p > 0.05). 
 
 
 
 
 
Figure  1.  Individual baseline  γH2AX-foci in non-irradiated  blood  sam- 
ples without iodine for each participant. Differences in mean γH2AX-foci 
were not signiﬁcant (p > 0.05). 
contributed to a greater  percentage of mean  γH2AX-foci induc- 
tion at lower radiation  doses  (Table 3). This was demonstrated 
for the lymphocytes  exposed  to 70 mGy whereby the presence 
of iodine increased  γH2AX-foci by 44-111% whilst for 450 mGy 
the  mean  increase  in γH2AX-foci  was  11-59%. The individual 
response  for each  participant  demonstrated a similar response 
and an increasing trend in mean γH2AX-foci induction as iodine 
concentration increased. The results of our 250 mGy dataset  for 
each participant  are demonstrated in Fig. 5. 
 
 
3.2.    Lymphocytes irradiated in vivo 
 
Pre irradiation samples  contained  no more than  an average  of 
0.07 γH2AX-foci. Participants who received ICM during paediatric 
cardiac catheterization  were found  to have  47% greater  mean 
γH2AX-foci (0.9±0.07) compared  to those  who did not  receive 
ICM (0.48±0.04). Following an  adjustment using  the  ANCOVA 
test  to account  for the  effect of radiation dose  upon  DNA DSB 
induction,  ICM was found  to have caused  an average  increase 
of 19% γH2AX-foci  (0.086±0.08) compared   to  those  who  did 
not receive ICM (0.7±0.019) (Table 4). 
 
 
4.    DISCUSSION 
 
The γH2AX assay has proven  to be a reliable, reproducible  and 
sensitive  biomarker  for the  detection  of DNA DSBs in human 
 
Table  2.  Comparison of γH2AX-foci in blood  samples  con- 
taining concentrations of iodine in non-irradiated  blood 
samples
 .   
  Radiation dose 
(mGy) 
 
mg iodine per ml 
blood 
 
Increase in mean 
foci (%) 
70 15 44 
 17.5 82 
 30 89 
 35 111 
 45 89 
Figure 2.   Example images after immunoﬂuorescence of DNA in periph-  52.5 99 
eral blood lymphocytes, scale 20 μm: (a) 0 mGy and (b) 450 mGy (arrows 140 15 42 
indicate individual γH2AX-foci).  17.5 50 
  30 75 
  35 64 
  45 86 
  52.5 76 
 250 15 14 
  17.5 31 
  30 35 
  35 35 
  45 49 
  52.5 49 
 450 15 11 
  17.5 36 
  30 25 
  35 48 
  45 33 
  52.5 59 
Figure  3.   Mean γH2AX foci induction  with standard  error for 0 – 450    
mGy without the presence  of iodine.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure   4.   Mean  γH2AX-foci  induction   with  standard   error  for  70  - 
450mGy with 0 - 52.5 mg iodine per mL blood for three  healthy volun- 
teers. Compared to the control samples of 0mGy in Table 2, a signiﬁcant 
difference was observed  for 70mGy, 140mGy, 250mGy and 450mGy 
(p < 0.05). Compared to the control sample with 0 mg iodine per mL blood, 
one-way ANOVA with bonferoni correction for inequalities demonstrated 
no signiﬁcant difference for 15 mg iodine per mL blood (p > 0.05) and a 
signiﬁcant difference for 17.5 – 52.5 mg iodine per mL blood (p < 0.05). 
Multiple R-squared for radiation dose and iodine was 0.96. 
 
 
lymphocyte cells following exposure to ionizing radiation 
(21,24,27). This study  has  assessed  γH2AX-foci  in lymphocytes 
following in vitro irradiation (0-450 mGy) of venous whole blood 
with   and   without   the   presence    of   iodine.   The   potential 
 
 
 
 
Table 3.  The percentage increase in γH2AX-foci in irradiated 
samples containing iodine concentrations compared  to sam- 
ples irradiated without the presence  of iodine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.   Mean γH2AX foci induction  with standard  error for 250 mGy 
with 0 - 52.5 mg iodine per mL blood for participants  1-3. 
 
 
enhancement effect  of  ICM in vivo was  also  investigated   in 
children undergoing cardiac catheterization.  Detection  of 
γH2AX-foci  has  enabled  the  quantiﬁcation   of the  number  of 
DNA DSBs, a potentially carcinogenic lesion. The in vitro radiation 
doses and iodine concentrations investigated  were similar to our 
in vivo observations  and also enabled  comparison  with previous 
published studies (21–25,28).  A total of six iodine concentrations 
were investigated  in vitro and  represents  a greater  number  of 
iodine  concentrations previously  investigated.  This study  also
    
 
Table  4.  Mean  in vivo γH2AX foci induction  for patients 
undergoing paediatric cardiac catheterization  with and with 
iodinated  contrast media 
effect is a process that occurs when an outer shell electron  ﬁlls 
an inner shell vacancy shell. This event may be accompanied by 
either  the  emission of a photon  that  has energy  equivalent  to 
the energy gap between the outer and inner electrons, or this en-
ICM group 
(n 57) 
Non-ICM 
group (n 12) 
ergy can instead  be transferred  to another  outer  shell electron 
that is then  ejected  from the atom (34). The result of additional 
photon  generation  and ejected  electrons may then be responsi-
Mean γH2AX-foci induction          0.09±0.07          0.48±0.04 ble for creating more free radicals and further DNA DSBs.
Mean γH2AX-foci induction 
with ANCOVA test 
0.7±0.019        0.86±0.008 Our in vitro results have demonstrated that DNA DSBs increase 
as a result of the presence  of ICM during irradiation in an average 
cell population  from three  healthy individuals. These results are
investigated  the in vivo effect of ICM in the presence  of ionizing 
radiation in children undergoing medical imaging. 
It has been established that as radiation dose increases a linear 
increase in the number  of DNA DSBs occurs (27,29). Yet there is 
uncertainty  in the literature regarding  the additional effect from 
the presence  of ICM in blood during irradiation. As found in pre- 
vious studies (21–25), the presence  of iodine did not result in a 
signiﬁcant difference in γH2AX-foci in non-irradiated  blood sam- 
ples owing to its few pharmacological  and  cellular effects (30). 
However  our  study  has  found  a  signiﬁcant  increase  in mean 
γH2AX-foci for ≥17.5 mg iodine per mL blood during irradiation, 
beyond that caused by ionizing radiation. The in vitro increase in 
mean γH2AX-foci, as a result of the presence  of iodine during ir- 
radiation was highly signiﬁcant and up to 111%. For comparison, 
the in vitro increase in mean in γH2AX-foci, caused by increasing 
the  radiation  dose  from  70  to  200  mGy  in  our  study,  was 
118-181%. Therefore the  amount  of DNA DSBs caused  by the 
presence  of iodine in vitro was comparable  to what would occur 
by increasing the radiation dose. Additionally our in vivo obser- 
vations  demonstrated an  average  increase  of 19% more  DNA 
DSBs  in   children   undergoing  cardiac   catheterization    who 
received an average of 19 mg iodine per mL blood. 
The main paradigm of ionizing radiation damage  is thought to 
occur as a consequence of the photoelectric  effect; the emission 
of a k-shell electron following the absorption  of energy from an 
X-ray photon. Photoelectrons deposit their energy to orbital elec- 
trons in absorbing atoms (31). This event may damage  the chem- 
ical bonds of DNA directly, or indirectly by causing the radiolysis 
of water; the disassociation of water molecules into its constitu- 
ent atoms. The result of which is the production of highly reactive 
free radicals that have a high degree  of reactivity with their sur- 
rounding  environment,  because  they can either donate  an elec- 
tron, or accept  an electron  from other  molecules  (32). Clusters 
of free radicals, formed adjacent  to DNA are signiﬁcant because 
they react with the covalent and hydrogen bonds of DNA strands. 
Compared  to  the  chemical  elements   carbon  (z=6), hydrogen 
(z=1), oxygen (z=8) and nitrogen (z=7), which make up more than 
95% of the human body, iodine has a much greater atomic num- 
ber (z=53). Therefore it is plausible that the presence  of iodine, 
containing a much greater number  of electrons, results in an in- 
crease  in the  photoelectric  effect and  the  consequent amount 
of free radical production.†  The reason  that  the  amount  of ob- 
served DNA DSBs was signiﬁcant in our study is likely because 
of the K-edge absorption  of iodine (34 keV), which is also in the 
energy range of photons  used in medical imaging. Additionally 
the increase in photoelectrons, caused by the presence  of iodine, 
is also thought to contribute  to the Auger effect (33). The Auger 
 
 
†Correction  added   on  21  December   2015,  after  ﬁrst  online  publication: 
“k-shell” was removed  from this sentence. 
in broad  agreement with  previously published  in vitro results 
(21–23). The in vitro percentage increase in mean  γH2AX-foci in 
our  study  for 35-45 mg  iodine  per  mL blood  (33-111%) was 
comparable  to the  in vitro ﬁndings  observed  30 minutes  post 
irradiation in vitro by Pathe et al. (22) (36-95%) who investigated 
40 mg iodine per mL blood. The percentage increase observed 
by Grudzenski et al. (21) for 33 mg iodine per mL blood at 500 
mGy (60%) was also comparable  to the 48% that  we observed 
in vitro using 35 mg iodine per mL blood at 450 mGy. 
Jost et al. (25) investigated two iodine concentrations of 5 mg 
and  50 mg  per  mL of blood  and  a radiation dose  range  of 25 
mGy-1 Gy, ﬁnding  consistent  evidence  of additional  DNA DSBs 
for 50 mg iodine per mL blood and not for 5 mg iodine per mL 
blood. Jost et al. (25) concluded that 50 mg per mL blood is beyond 
a typical iodine concentration administered in diagnostic CT exam- 
inations but  did not  investigate other  concentrations of iodine. 
Joubert et al. (28) did not ﬁnd additional DNA damage  in the pres- 
ence of 10 mg iodine per mL blood during irradiation of endothe- 
lial cells. The ﬁndings by Jost et al. (25) and Joubert et al. (28) are 
consistent with the ﬁndings of our in vitro results, demonstrating 
no additional DNA damage  below 17.5 mg iodine per mL blood. 
The percentage in vitro increase  in mean  γH2AX-foci for the 
presence  of 15 mg iodine per mL blood (11%) was less than that 
found  by Deinzer et al. (23) (38%) for a similar radiation  dose. 
Furthermore  our in vitro results for 15 mg iodine per mL blood 
were  not  statistically signiﬁcant  for 70-450 mGy whilst Deizner 
et al. (23) found signiﬁcant enhancement with 7.5 and 15 mg iodine 
per mL blood using 20 and 500 mGy. It could be postulated that 
these differences may be due to the use of multiple volunteers in 
this study. However work assessing intra and  inter variability of 
baseline and  radiation induced  γH2AX-foci in 32 healthy  adults, 
demonstrated  that   genetic   or  environmental  factors  do  not 
appear to signiﬁcantly modify baseline and radiation-induced 
γH2AX-foci yields (35). One reason for the differences in the results 
from this study and (23), may be because  the Deinzer et al. (23) 
study mixed ICM with PBS and blood prior to irradiation whereas 
this  study  irradiated ICM and  blood  prior to  adding PBS.  The 
presence  of PBS in addition to blood during irradiation may have 
exaggerated DNA damage  due to the production of more free radi- 
cals from radiolysis due to the presence  of more water molecules. 
Beels et al. (24) investigated  0-20 mg  iodine  per  mL blood 
using 0-50 mGy, and did not ﬁnd evidence  of DNA damage  en- 
hancement. Radiation doses of 50 mGy may therefore  require a 
larger concentration of iodine (>20  mg mL blood) to produce 
an enhancement effect. Beels et al. (24) comment  that the iodine 
concentrations and radiation doses they investigated  are within 
the  normal limits of CT examinations.  Our study considers  PCC 
procedures,  which can involve the  use of greater  volumes and 
concentrations of ICM compared  to CT. For imaging of an ana- 
tomical structure such as the left ventricle, an injection of a large 
bolus of ICM would result in concentrations of iodine >50 mg
  
  
 
per  mL blood  during  irradiation  for an  average  patient   (36). 
Although more difﬁcult to estimate,  it is likely that  comparable 
iodine concentrations may be present during imaging of the cor- 
onary arteries during these procedures. PCC also involves a large 
proportion  of continuous  ﬂuoroscopic  imaging  of the  cardiac 
region therefore  consideration  should be given to any remnant 
iodine concentrations, which may occur in the circulating blood. 
According to ICM manufacturer  guidance  notes  the  maximum 
amount  of ICM administered during cardiac procedures should 
not exceed  5 mLs/kg. A typical volume of blood for an average 
adult, 5 mLs/kg of ICM corresponds  to approximately 20-25 mg 
iodine per mL blood. It is known that doses of >20-25 mg iodine 
per mL blood, are frequently exceeded  in adult catheterizations 
during repair of the left anterior  descending artery (37). There- 
fore, the   greatest   concentrations  of  iodine   investigated   by 
Jost et al. (25) are clinically relevant  to complex interventional 
procedures, which may on occasions exceed ICM dose limits in PCC. 
Our study demonstrated a greater magnitude of DNA damage 
by the presence  of iodine at the lowest observed radiation doses. 
This meant  that  iodine contributed to a greater  percentage of 
the total number  of DNA DSBs than  ionizing radiation at lower 
radiation doses. Pathe et al. (22) and Deinzer et al. (23) also made 
this observation.  The mechanism  for this is unclear. It may be 
that the presence  of iodine reaches  a threshold  effect, which is 
independent of  increasing  radiation  dose.  Regardless  of  the 
reason, the results indicate that for a given iodine concentration, 
an increase in radiation dose is not likely to exaggerate the DNA 
damage  caused by the presence  of iodine. 
The mean baseline levels for the three volunteers in this inves- 
tigation (0.02) were typical of the numbers  expected  in healthy 
volunteers (22,29). Similarly to this study, previous investigations 
also used manual foci scoring. Although 100 cells were scored in 
this study, baseline levels compared  well with Deinzer et al. (23) 
who  scored  200  cells per  sample  and  Pathe  et  al. (22) who 
scored either 40 cells or until 40 foci per sample were detected. 
Joubert et al. (28) and Jost et al. (25) did not specify the number 
of cells that were counted. 
Our in vivo observations demonstrate that children can receive 
considerable  levels of ICM, up  to  65 mg  iodine  per  mL blood 
during cardiac catheterizations. Therefore, the greatest concentra- 
tions of iodine investigated  by Beels et al. (24) and Jost et al. (25) 
are clinically relevant to complex interventional procedures. The 
average 19% increase in DNA DSBs, in those patients that received 
an average of 19 mg iodine per mL blood during cardiac catheter- 
ization, is in agreement with out in vitro ﬁndings. Our in vivo re- 
sults support  previous evidence  of DNA damage  enhancement 
from contrast  enhanced CT (21,22,38).  The average  amount  of 
DNA damage  caused by the presence  of ICM was much lower in 
our study than Pathe et al. (22) (58%) and Piechowiak et al. (38) 
(107%) but  were  more  similar to  Grudzenski et al. (21) (30%). 
The reason that the enhancement effect caused by ICM was lower 
in our study was because cardiac catheterizations take place over 
a longer period time (up to two hours) and therefore iodine would 
have begun to accumulate in the renal system rather than remain 
completely  in the  blood  circulation. Our in vivo ﬁndings  have 
helped demonstrate the clinical relevance of ICM. The established 
linear response of DSB to ionizing radiation, as well as ionizing ra- 
diation and cancer risk (39), suggest  that the presence  of iodine 
during in vivo irradiations may increase the risk of cancer induc- 
tion by 19%. Consequently these ﬁndings are relevant to clinicians 
who perform contrast-enhanced procedures  involving higher 
amounts  of ionising radiation in children. Our current work and 
data from elsewhere (40) suggest  that average radiation induced 
cancer  risk to  children  undergoing cardiac  catheterization   is 
approximately  1  in  1000. Children  may  also  receive  multiple 
procedures during childhood resulting in a cumulative cancer risk 
that may be as high as 6.5% (41). 
A number  of limitations exist within this study. The linear no 
threshold  theory states  that there  is no safe radiation dose and 
that cancer risk increases linearly with radiation exposure (39). It 
is also established that there is a linear increase in the generation 
of DSBs with increasing  radiation  exposure  (42). However our 
study has not reliably quantiﬁed the additional cancer risk as a re- 
sult of the additional DSBs caused  by the presence  of iodine in 
the blood during irradiation. It must also be acknowledged that 
the DNA DSBs observed in this study captured  the repair process 
of a DSB 30 minutes post irradiation when γH2AX accumulation 
is most  prevalent.  DSBs are  primarily repaired  by two  cellular 
pathways  known  as non-homologous end  joining (NHEJ) and 
homologous  recombination  (HR) (43) and  γH2AX is known  to 
disperse once a DSB is repaired (44). This study therefore  did not 
determine  whether  non-repair  or misrepair  occurred  for any of 
the observed DNA damage. The presence of γH2AX-foci >20 hours 
following ionizing radiation exposure  is thought to represent 
aberrant  chromatin structure by illegitimate strand rejoining (45). 
Consequently it may be of interest to investigate DNA DSB repair 
in as a result of the presence  of ICM during irradiation in future 
studies over a 24 hour period. Although this study also attempted 
to assess  DNA DSBs  in vivo, the  half-life of ICM in the  vascular 
circulation and its rapid distribution into extra cellular ﬂuid may re- 
sult in a reduction of iodine concentrations in the circulating blood. 
This may result in gradual decrease  in concentrations of iodine in 
the ﬁeld of view during  lengthy cardiac imaging as opposed to 
an accumulation of iodine. At present  the effects of fractionated 
high doses of ionizing radiation, such as those used in radiother- 
apy, have been  proven  to cause cellular hypersensitivity (46,47). 
Cardiovascular ﬂuoroscopy procedures would also involve fraction- 
ated  radiation  exposures  in combination with ICM however  evi- 
dence  of hypersensitivity  in low to  moderate doses  associated 
with diagnostic imaging is less clear compared to high doses asso- 
ciated with radiotherapy (48,49). This should be considered in fu- 
ture investigation on the effects of ICM. This study used one type 
of ICM because  a variation in amounts  of DNA damage  as a result 
of differing manufacturing brands  has  been  strongly disproven 
(23).  The  additional  DNA  damage   caused  by  the  presence   of 
iodine in lymphocytes cells does not portray the affect upon DNA 
in cells elsewhere  in the body. Peripheral blood lymphocyte cells 
were used  because  an abundance of them  are easily obtained, 
they  are  non-cycling and  have  very low background   levels of 
DNA DSBs, giving excellent sensitivity. With regards to the effects 
of other  circulating cells, there  has been  little work done  in this 
area. This is likely because red blood cells and platelets do not have 
DNA. Neutrophils do not appear to form γH2AX-foci at the same in- 
tensity following irradiation making it difﬁcult to quantify any addi- 
tional damage  with contrast medium (50). The dispersal of iodine 
to all areas of the body may warrant future investigations focusing 
upon the effects of other regions of the body. 
Future consideration  should be given to the excretion time of 
ICM patients. The plasma half-life of ICM in patients  with normal 
renal function is reported  to range  from 30 minutes  (30) up to 
two hours (51) whilst renal impairment  can result in a half-life 
of ICM of ≥ 30 hours  (52). Remnant  iodine  concentrations in 
the blood circulation may render an individual more susceptible 
to DNA damage  enhancement if they were to undergo  further
    
medical radiation exposure. At present  there has been no inves- 
tigation  into a link between ICM and  increased  risk of cancer, 
which may be an interesting  area of future research. In particular 
it may be  of interest  to investigate  a link between iodine  en- 
hanced  DNA damage  and  risk of renal  cell carcinoma  caused 
by the  presence  of contrast-enhanced renal examinations.  Our 
study did not  determine the  effects of ICM in the  presence  of 
radiation   on  bone   marrow,  therefore   a  future   study  could 
consider the  inﬂuence  of ICM upon  progenitor  cells. It may be 
of interest to assess for chromosome aberrations  in white blood 
cells one  - two  years  post  irradiation  with  ICM to  determine 
whether  the bone marrow received additional damage. 
 
5.    CONCLUSION 
 
The  in  vitro  ﬁndings  in  our  study  have  demonstrated that 
signiﬁcant  additional  DNA damage   occurs  from  irradiation  of 
70-450 mGy in the  presence  of ≥17.5 mg iodine per mL blood 
beyond   that   of  the   radiation   induced   damage   alone.  Our 
in vivo observations  have  demonstrated the  clinical relevance 
to adult and paediatric patients undergoing interventional 
cardiovascular procedures  of the  enhancement effect of ICM. 
Iodine during irradiation was found to cause a comparable amount 
of DNA damage  to that caused  by increasing the radiation dose. 
Intravenous urography, micturating cystourethrography and con- 
trast enhanced CT of the abdomen may also be of concern. The 
administration of ICM should  be taken into consideration  and 
investigation should focus on the potential beneﬁt  of optimizing 
the dosage  of ICM. Future investigation could explore the poten- 
tial additional cancer risk caused by ICM. 
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